Tianjin TEDA Biomedical Engineering Company Limited (8189.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 569.72M |
| Enterprise Value | 650.28M |
| P/E Ratio | -1.99 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0.4 |
| Price/Book Ratio | 21.3 |
| Enterprise/Revenue | 0.52 |
| Enterprise/EBITDA | -8.15 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.2 |
| Operating Margin | -0.07 |
AD
Management Effectiveness
| Return On Assets | -0.5 |
| Return On Equity | -2.42 |
Income Statement
| Revenue | 509.43M |
| Revenue/Share | 0.32 |
| Gross Profit | 34.75M |
| EBITDA | -14.32M |
| Net Income | -88.47M |
| Diluted EPS | -0.04 |
Balance Sheet
| Total Cash | 29.22M |
| Total Cash/Share | 0.01 |
| Total Debt | 109.79M |
| Total Debt/Equity | 8.98 |
| Current Ratio | 0.75 |
| Book Value Per Share | 0 |
Price History
| 52-Week Change | -67.78 |
| 52-Week High | 0.49 |
| 52-Week Low | 0.11 |
| Moving Average 50 Days | 0.16 |
| Moving Average 200 Days | 0.27 |
Statistics
| Average Volume | 574,354 |
| Shares Outstanding | 2.13B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
